{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:22:34Z","timestamp":1775744554248,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.euroneuro.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T03:38:13Z","timestamp":1666237093000},"page":"30-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-7126","authenticated-orcid":false,"given":"Giovanna","family":"Fico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3927-4810","authenticated-orcid":false,"given":"Ulker","family":"Isayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-1181","authenticated-orcid":false,"given":"Michele","family":"De Prisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5961-6032","authenticated-orcid":false,"given":"Vincenzo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brisa","family":"Sol\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-9454","authenticated-orcid":false,"given":"Laura","family":"Montejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iria","family":"Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nestor","family":"Arbelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-0866","authenticated-orcid":false,"given":"Marta","family":"Gomez-Ramiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Pintor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Carpiniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-6413","authenticated-orcid":false,"given":"Mirko","family":"Manchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Murru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.10.004_bib0001","unstructured":"AHRQ Comparative Effectiveness Reviews - NCBI Bookshelf [WWW Document], n.d. URL https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK42934\/(accessed 12.17.21)."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0002","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jad.2020.05.149","article-title":"COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry","volume":"274","author":"Anmella","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0003","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejpsy.2020.10.004","article-title":"Are dopamine and serotonin involved in COVID-19 pathophysiology?","volume":"35","author":"Attademo","year":"2021","journal-title":"Eur. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0004","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0005","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0006","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","article-title":"MOOSE Reporting guidelines for meta-analyses of observational studies","volume":"156","author":"Brooke","year":"2021","journal-title":"JAMA Surg."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091400","article-title":"Combination therapy with fluoxetine and the nucleoside analog GS-441524 exerts synergistic antiviral effects against different SARS-CoV-2 variants in vitro","volume":"13","author":"Brunotte","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.231","article-title":"Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine","volume":"4","author":"Caiaffo","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0009","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2021.02.002","article-title":"Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population","volume":"229","author":"Canal-Rivero","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0010","article-title":"Mortality comparison between the first and second\/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: a multicentre retrospective cohort study. The Lancet regional health","volume":"11","author":"Carbonell","year":"2021","journal-title":"Europe"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0011","article-title":"Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19\u2014a report for the GCS-NeuroCOVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0013","article-title":"Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort","volume":"8","author":"Clelland","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0014","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1073\/pnas.1720553115","article-title":"Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration","volume":"115","author":"Cloutier","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111437","article-title":"Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection","volume":"138","author":"Creeden","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40568","article-title":"Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19","volume":"4","author":"Denson","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0019","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/acps.13304","article-title":"Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients","volume":"143","author":"Diez-Quevedo","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0020","doi-asserted-by":"crossref","unstructured":"Eick, S.M., Goin, D.E., Chartres, N., Lam, J., Woodruff, T.J., 2020. Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools. doi:10.1186\/s13643-020-01490-8.","DOI":"10.1289\/isee.2020.virtual.P-1151"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0021","doi-asserted-by":"crossref","first-page":"24436","DOI":"10.1038\/s41598-021-03898-1","article-title":"The outcomes of patients with diabetes mellitus in The Philippine CORONA Study","volume":"11","author":"Espiritu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0022","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0023","article-title":"Can SSRI\/SNRI antidepressants decrease the \u201ccytokine storm\u201d in the course of COVID-19 pneumonia?","author":"Fei","year":"2021","journal-title":"Panminerva Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0026","doi-asserted-by":"crossref","unstructured":"Govind, R., Fonseca De Freitas, D., Pritchard, M., Hayes, R.D., Maccabe, J.H., 2021. Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. doi:10.1192\/bjp.2020.151.","DOI":"10.2139\/ssrn.3605316"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105534","article-title":"Associations between COVID-19 and 30-day thromboembolic events and mortality in\u00a0 people with dementia receiving antipsychotic medications","volume":"167","author":"Harrison","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0028","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2147\/TCRM.S3470","article-title":"Interleukin-6 inhibitors in the treatment of rheumatoid arthritis","volume":"4","author":"Hennigan","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0029","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2458-13-154","article-title":"Are healthcare workers\u2019 intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review","volume":"13","author":"Herzog","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0032","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1038\/s41380-021-01021-4","article-title":"Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study","volume":"26","author":"Hoertel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0031","series-title":"Observational study of haloperidol in hospitalized patients with COVID-19","author":"Hoertel","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbrc.2020.08.116","article-title":"RNA-dependent RNA polymerase: structure, mechanism, and drug discovery for COVID-19","volume":"538","author":"Jiang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121023","article-title":"Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection","volume":"607","author":"Khater","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0038","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2020.22760","article-title":"Fluvoxamine vs Placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial","volume":"324","author":"Lenze","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101111","article-title":"Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action","volume":"40","author":"Liu","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0041","article-title":"Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition","author":"Liu","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0042","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.euroneuro.2022.04.006","article-title":"Letter to the editor about the article \u201cPsychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): recommendations for health care professionals\u201d (Falconi A et\u00a0al., 2022)","volume":"59","author":"Llach","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.euroneuro.2021.04.019","article-title":"Mind long COVID: psychiatric sequelae of SARS-CoV-2 infection","volume":"49","author":"Llach","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104862","article-title":"Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay","volume":"111","author":"Loschwitz","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118889","article-title":"Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro","volume":"266","author":"Lu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0047","doi-asserted-by":"crossref","unstructured":"McKeigue, P.M., Kennedy, S., Weir, A., Bishop, J., McGurnaghan, S.J., McAllister, D., Robertson, C., Wood, R., Lone, N., Murray, J., Caparrotta, T.M., Smith-Palmer, A., Goldberg, D., McMenamin, J., Guthrie, B., Hutchinson, S., 2021. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. doi:10.1186\/s12916-021-01907-8.","DOI":"10.1186\/s12916-021-01907-8"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104490","article-title":"Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review","volume":"106","author":"Mohamed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-013-3383-3","article-title":"Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics","volume":"231","author":"Mondelli","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0051","doi-asserted-by":"crossref","DOI":"10.1186\/s40345-020-00191-4","article-title":"Lithium's antiviral effects: a potential drug for CoViD-19 disease?","volume":"8","author":"Murru","year":"2020","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0052","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/2472555220975672","article-title":"COMPARE analysis, a bioinformatic approach to accelerate drug repurposing against Covid-19 and other emerging epidemics","volume":"26","author":"Naasani","year":"2021","journal-title":"SLAS Discov."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0053","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.2503","article-title":"Association Between antipsychotic use and COVID-19 mortality among people with serious mental illness","volume":"78","author":"Nemani","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0054","article-title":"Clozapine treatment and risk of severe COVID-19 infection","author":"Ohlis","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.33090","article-title":"Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants","volume":"4","author":"Oskotsky","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0056","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320942703","article-title":"Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches","volume":"10","author":"Ostuzzi","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0057","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0058","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00109-020-01980-1","article-title":"Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis","volume":"98","author":"Pandey","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0059","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-21769-0","article-title":"Proliferation and apoptosis of T lymphocytes in patients with bipolar disorder","volume":"8","author":"Pietruczuk","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0061","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: the reCoVery study","volume":"46","author":"Plaze","year":"2020","journal-title":"Encephale"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0062","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17145171","article-title":"Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain","volume":"17","author":"Poblador-Plou","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0063","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0064","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S2213-2600(20)30552-X","article-title":"Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study","volume":"9","author":"Pun","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.euroneuro.2021.09.001","article-title":"Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review","volume":"54","author":"Reininghaus","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0066","article-title":"Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial","volume":"0","author":"Reis","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0067","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5266","article-title":"Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis","volume":"11","author":"Rosen","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0068","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0069","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/22221751.2020.1829082","article-title":"Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine","volume":"9","author":"Schloer","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0070","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/bph.15418","article-title":"Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro","volume":"178","author":"Schloer","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0071","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0072","doi-asserted-by":"crossref","unstructured":"Smith, P.O., Jin, P., Rahman, K.M., 2021. Strategies for drug repurposing against coronavirus targets. Current research in pharmacology and drug discovery 100072. doi:10.1016\/J.CRPHAR.2021.100072.","DOI":"10.1016\/j.crphar.2021.100072"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.652688","article-title":"Fluvoxamine: a review of its mechanism of action and its role in COVID-19","volume":"12","author":"Sukhatme","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111997","article-title":"Laser irradiated phenothiazines: new potential treatment for COVID-19 explored by molecular docking","volume":"211","author":"Udrea","year":"2020","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0075","doi-asserted-by":"crossref","first-page":"10035","DOI":"10.18632\/aging.103449","article-title":"Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?","volume":"12","author":"Viel","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0076","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/wps.20806","article-title":"Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States","volume":"20","author":"Wang","year":"2021","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0077","series-title":"WHO Official Updates - Coronavirus Disease 2019 [WWW Document]","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0078","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/NDT.S123121","article-title":"Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder","volume":"13","author":"Yoshimura","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0079","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J. Evid. Based Med."},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-017-1539-0","article-title":"The metabolic side effects of 12 antipsychotic drugs used for the treatment of Schizophrenia on glucose: a network meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.10.004_bib0081","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:05:29Z","timestamp":1760378729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22008720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":73,"alternative-id":["S0924977X22008720"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.10.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}